Renal Cell Carcinoma: Disease Detection, Translocation Monitoring, & More
Physician’s Weekly reviewed renal cell carcinoma-targeted research presented at the 2024 ESMO annual meeting.
Nov 6, 2024
MEETING BRIEF
ESMO 2024
The latest news from ESMO 2024 focused on RCC including abstracts, features, and helpful conference information.
ESMO 2024: Renal Cell Carcinoma Highlights
ESMO 2024: Renal Cell Carcinoma Highlights
During the 2024 annual ESMO Congress, multiple poster sessions focused on the treatment of renal cell carcinoma (RCC).
Protein Glycosylation Predicts Resistance and Treatment Response in aRCC
Protein Glycosylation Predicts Resistance and Treatment Response in aRCC
Protein glycosylation may predict response to NIVO+CABO vs SUN in aRCC, with glycopeptides and complement proteins linked to progression-free survival and outcomes.
Immunotherapy Beats Standard Care in Metastatic Non-Clear Cell Renal Cancer
Immunotherapy Beats Standard Care in Metastatic Non-Clear Cell Renal Cancer
The SUNNIFORECAST trial (LBA75), presented by Dr. Lothar Bergmann from Germany on Friday,...
Did You Attend ESMO 2024 in Person?
Did You Attend ESMO 2024 in Person?
Let us know if you attended ESMO 2024 in person.
Advertisement
PW QUIZ
Advertisement
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
